Abstract
Antidepressants are the mainstay of drug treatment for moderate or severe postpartum depression. Knowledge of predictors of response could help optimize treatment and reduce the adverse consequences of postpartum depression. The purpose of this systematic review was to ascertain predictors of response or remission to antidepressant treatment in women with postpartum depression. The electronic databases of MEDLINE/PubMed, PsycINFO, CINAHL, Cochrane Database of Systematic Reviews, and Evidence-based Medicine Reviews were searched through December 2019. The search was limited to studies published in the English language. Reference lists of articles that met the inclusion criteria were also searched. We identified some predictors of response and remission that could potentially assist in the optimization of drug treatment of postpartum depression; however, caution is needed to apply these findings in clinical practice due to the heterogeneous nature of postpartum depression. The results of our review highlight the urgent need to identify predictors of response, non-response, or remission to antidepressants in women with postpartum depression.
Similar content being viewed by others
Data availability
Not applicable.
References
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington
Appleby L, Warner R, Whitton A, Faragher B (1997) A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 314:932–936
Arnow BA, Blasey C, Williams LM, Palmer DM, Rekshan W, Schatzberg AF, Etkin A, Kulkarni J, Luther JF, Rush AJ (2015) Depression subtypes in predicting antidepressant response: a report from the iSPOT-D trial. Am J Psychiatry 172:743–750. https://doi.org/10.1176/appi.ajp.2015.14020181
Azorin J-M, Angst J, Gamma A, Bowden CL, Perugi G, Vieta E, Young A (2012) Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study. J Affect Disord 136:710–715. https://doi.org/10.1016/j.jad.2011.10.003
Banti S, Mauri M, Oppo A, Borri C, Rambelli C, Ramacciotti D, Montagnani MS, Camilleri V, Cortopassi S, Rucci P, Cassano GB (2011) From the third month of pregnancy to 1 year postpartum. Prevalence, incidence, recurrence, and new onset of depression. Results from the Perinatal Depression-Research & Screening Unit study. Compr Psychiatry 52:343–351
Battle CL, Salisbury AL, Schofield CA, Ortiz-Hernandez S (2013) Perinatal antidepressant use: understanding women’s preferences and concerns. J Psychiatr Pract 19:443–453. https://doi.org/10.1097/01.pra.0000438183.74359.46
Bauer M, Pretorius HW, Constant EL, Earley WR, Szamosi J, Brecher M (2009) Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. J Clin Psychiatry 70:540–549
Bloch M, Meiboom H, Lorberblatt M, Bluvstein I, Aharonov I, Schreiber S (2012) The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression. J Clin Psychiatry 73:235–241. https://doi.org/10.4088/JCP.11m07117
Cannon C, Nasrallah HA (2019) A focus on postpartum depression among African American women: a literature review. Ann Clin Psychiatry 30:e1–e6
Cauli G, Iapichino E, Rucci P, Quartieri Bollani M, Marconi AM, Bassi M, Gala C (2019) Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period. J Affect Disord 246:148–156. https://doi.org/10.1016/j.jad.2018.12.028
Centers for Disease Control and Prevention (2017) Depression among women. https://www.cdc.gov/reproductivehealth/depression/index.htm. Accessed 28 Jun 2019
Chan JWY, Lam SP, Li SX, Yu MWM, Chan NY, Zhang J, Wing YK (2014) Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder. Sleep 37:911–917. https://doi.org/10.5665/sleep.3658
Cohen LS, Viguera AC, Bouffard SM, Nonacs RM, Morabito C, Collins MH, Ablon JS (2001) Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 62:592–596
Cutler AJ, Montgomery SA, Feifel D, Lazarus A, Åström M, Brecher M (2009) Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. J Clin Psychiatry 70:526–539
De Crescenzo F, Perelli F, Armando M, Vicari S (2014) Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials. J Affect Disord 152–154:39–44. https://doi.org/10.1016/j.jad.2013.09.019
Di Florio A, Meltzer-Brody S (2015) Is postpartum depression a distinct disorder? Curr Psychiatry Rep 17:76. https://doi.org/10.1007/s11920-015-0617-6
Dinwiddie KJ, Schillerstrom TL, Schillerstrom JE (2018) Postpartum depression in adolescent mothers. J Psychosom Obstet Gynecol 39:168–175. https://doi.org/10.1080/0167482X.2017.1334051
Field T (2010) Postpartum depression effects on early interactions, parenting, and safety practices: a review. Infant Behav Dev 33:1–6. https://doi.org/10.1016/j.infbeh.2009.10.005
Frodl T (2017) Recent advances in predicting responses to antidepressant treatment. F1000Research 6:619. https://doi.org/10.12688/f1000research.10300.1
Gedge L, Lazowski L, Murray D et al (2010) Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression. Neuropsychiatr Dis Treat 6:501–508. https://doi.org/10.2147/ndt.s12433
Grigoriadis S, Wilton AS, Kurdyak PA, Rhodes AE, VonderPorten EH, Levitt A, Cheung A, Vigod SN (2017) Perinatal suicide in Ontario, Canada: a 15-year population-based study. C Can Med Assoc J 189:E1085–E1092. https://doi.org/10.1503/CMAJ.170088
Guintivano J, Manuck T, Meltzer-Brody S (2018) Predictors of postpartum depression. Clin Obstet Gynecol 61:1–603. https://doi.org/10.1097/GRF.0000000000000368
Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296
Hantsoo L, Ward-O’Brien D, Czarkowski KA, Gueorguieva R, Price LH, Epperson CN (2014) A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology 231:939–948. https://doi.org/10.1007/s00213-013-3316-1
Hendrick V, Altshuler L, Strouse T, Grosser S (2000) Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment. Depress Anxiety 11:66–72
Hymas R, Girard L-C (2019) Predicting postpartum depression among adolescent mothers: a systematic review of risk. J Affect Disord 246:873–885. https://doi.org/10.1016/j.jad.2018.12.041
Kettunen P, Koistinen E, Hintikka J (2014) Is postpartum depression a homogenous disorder: time of onset, severity, symptoms and hopelessness in relation to the course of depression. BMC Pregnancy Childbirth 14:402. https://doi.org/10.1186/s12884-014-0402-2
Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. J Gen Intern Med 16:606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Masse-Sibille C, Djamila B, Julie G, Emmanuel H, Pierre V, Gilles C (2018) Predictors of response and remission to antidepressants in geriatric depression: a systematic review. J Geriatr Psychiatry Neurol 31:283–302. https://doi.org/10.1177/0891988718807099
Milgrom J, Gemmill AW, Ericksen J, Burrows G, Buist A, Reece J (2015) Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial. Aust New Zeal J Psychiatry 49:236–245. https://doi.org/10.1177/0004867414565474
Misri S, Reebye P, Corral M, Milis L (2004) The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 65:1236–1241. https://doi.org/10.4088/JCP.v65n0913
Misri S, Abizadeh J, Eng AB et al (2015) An open-label study of quetiapine extended-release in a sample of postpartum women with bipolar II depressive episode. Curr Psychopharmacol 4:17–26. https://doi.org/10.2174/2211556004666150604235028
Misri S, Swift E, Abizadeh J, Shankar R (2016) Overcoming functional impairment in postpartum depressed or anxious women: a pilot trial of desvenlafaxine with flexible dosing. Ther Adv Psychopharmacol 6:269–276. https://doi.org/10.1177/2045125316656297
Molenaar NM, Brouwer ME, Kamperman AM, Burger H, Williams AD, Hoogendijk WJG, Bockting CLH, Lambregtse-van den Berg MP (2019) Recurrence of depression in the perinatal period: clinical features and associated vulnerability markers in an observational cohort. PLoS One 14:e0212964. https://doi.org/10.1371/journal.pone.0212964
Molyneaux E, Howard LM, McGeown HR et al (2014) Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev:CD002018. https://doi.org/10.1002/14651858.CD002018.pub2
Munk-Olsen T, Laursen TM, Meltzer-brody S et al (2012) Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Arch Gen Psychiatry 69:428–434. https://doi.org/10.1001/archgenpsychiatry.2011.157
National Institute for Health and Care Excellence (2014) Antenatal and postnatal mental health: clinical management and service guidance
Netsi E, Pearson RM, Murray L, Cooper P, Craske MG, Stein A (2018) Association of persistent and severe postnatal depression with child outcomes. JAMA Psychiatry 75:247–253. https://doi.org/10.1001/jamapsychiatry.2017.4363
Nonacs RM, Soares CN, Viguera AC, Pearson K, Poitras JR, Cohen LS (2005) Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol 8:445–449. https://doi.org/10.1017/S1461145705005079
O’Hara MW, Pearlstein T, Stuart S et al (2019) A placebo controlled treatment trial of sertraline and interpersonal psychotherapy for postpartum depression. J Affect Disord 245:524–532. https://doi.org/10.1016/j.jad.2018.10.361
Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium (2015) Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry 2:59–67. https://doi.org/10.1016/S2215-0366(14)00055-8
Santos H, Tan X, Salomon R (2017) Heterogeneity in perinatal depression: how far have we come? A systematic review. Arch Womens Ment Health 20:11–23. https://doi.org/10.1007/s00737-016-0691-8
Schatzberg AF, DeBattista C, Lazzeroni LC et al (2015) ABCB1 genetic effects on antidepressant outcomes: a report from the iSPOT-D trial. Am J Psychiatry 172:751–759. https://doi.org/10.1176/appi.ajp.2015.14050680
Sharma V (2013) Mixed depression in the postpartum period: diagnostic and treatment issues. J Psychiatry Neurosci 38:E30–E31. https://doi.org/10.1503/jpn.130150
Sharma V, Xie B, Campbell MK et al (2014) A prospective study of diagnostic conversion of major depressive disorder to bipolar disorder in pregnancy and postpartum. Bipolar Disord 16:16–21. https://doi.org/10.1111/bdi.12140
Sharma V, Khan M, Sommerdyk C (2015) Quetiapine in the acute treatment of bipolar postpartum depression: a chart review. J Clin Psychopharmacol 35:733–735. https://doi.org/10.1097/JCP.0000000000000415
Sharp D, Chew-Graham C, Tylee A et al (2010) A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess (Rockv) 14(iii–iv, ix–xi):1–153. https://doi.org/10.3310/hta14430
Stowe ZN, Casarella J, Landry J, Nemeroff CB (1995) Sertraline in the treatment of women with postpartum major depression. Depression 3:49–55. https://doi.org/10.1002/depr.3050030109
Suri R, Burt VK, Altshuler LL et al (2001) Fluvoxamine for postpartum depression. Am J Psychiatry 158:1739–1740. https://doi.org/10.1176/appi.ajp.158.10.1739
Suri R, Burt VK, Altshuler LL (2005) Nefazodone for the treatment of postpartum depression. Arch Womens Ment Health 8:55–56. https://doi.org/10.1007/s00737-005-0071-2
Vliegen N, Casalin S, Luyten P (2014) The course of postpartum depression: a review of longitudinal studies. Harv Rev Psychiatry 22:1–22. https://doi.org/10.1097/HRP.0000000000000013
Vu H, Shaya FT (2017) Predicting factors of depression, antidepressant use and positive response to antidepressants in perinatal and postpartum women. Clin Pract Epidemiol Ment Heal 13:49–60. https://doi.org/10.2174/1745017901713010049
Watson D, O’Hara MW, Simms LJ et al (2007) Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS). Psychol Assess 19:253–268. https://doi.org/10.1037/1040-3590.19.3.253
Wisner KL, Hanusa BH, Perel JM, Peindl KS, Piontek CM, Sit DKY, Findling RL, Moses-Kolko EL (2006) Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 26:353–360. https://doi.org/10.1097/01.jcp.0000227706.56870.dd
Wisner KL, Sit DKY, McShea MC et al (2013) Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiat 70:490–498. https://doi.org/10.1001/jamapsychiatry.2013.87
World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines, Geneva
Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS (2008) Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry 69:659–665
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The first author reports personal fees from the Neuroscience Education Institute and grants from Assurex, Genome Canada, Sage Therapeutics, Stanley Medical Research Institute, and Sunovion Pharmaceuticals, and participation on the advisory boards for Sunovion Pharmaceuticals and Otsuka, outside the submitted work. All other authors declare no conflict of interest.
Code availability
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sharma, V., Khan, M., Baczynski, C. et al. Predictors of response to antidepressants in women with postpartum depression: a systematic review. Arch Womens Ment Health 23, 613–623 (2020). https://doi.org/10.1007/s00737-020-01044-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-020-01044-w